How did the Covid-19 pandemic affect individuals with schizophrenia from Turkey?
COVID-19
Schizophrenia
qualitative
serious mental illness
Journal
The International journal of social psychiatry
ISSN: 1741-2854
Titre abrégé: Int J Soc Psychiatry
Pays: England
ID NLM: 0374726
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
pubmed:
22
3
2022
medline:
4
3
2023
entrez:
21
3
2022
Statut:
ppublish
Résumé
Serious mental illness, including schizophrenia, have been shown to be associated with psychosocial vulnerabilities in the face of adverse events. While individuals with schizophrenia might undergo many psychosocial difficulties during the COVID-19 pandemic, they might also not be affected, or report increased subjective well-being. This suggests that it is important to understand diverse impacts and further understand the unique experiences. To capture how the pandemic affected them and how they handled the challenges if there were any in the initial and more recent phases of the pandemic, 18 individuals with schizophrenia living in Turkey were interviewed. Thematic analysis of interviews resulted in four superordinate themes for both time points. Three themes related to the impact of the pandemic (i.e. burdens of COVID-19, positive impacts of COVID-19, no impact of COVID-19) indicated that they shared a number of challenges with the general population. Themes about the positive impacts and no impact also replicated the previous findings in this clinical population. One last theme named as facilitators of coping implied that the participants tried to deal with the burdens by using available resources, adapt to the changes in their daily living, and benefit from social interaction and support. To conclude, people with schizophrenia seem to be coping with challenges posed by the pandemic with diverse strategies and they seem to even experience psychological growth alongside with negative impacts. The individualized needs and potential for growth have pivotal implications for the management of the illness during the pandemic.
Sections du résumé
BACKGROUND
Serious mental illness, including schizophrenia, have been shown to be associated with psychosocial vulnerabilities in the face of adverse events. While individuals with schizophrenia might undergo many psychosocial difficulties during the COVID-19 pandemic, they might also not be affected, or report increased subjective well-being. This suggests that it is important to understand diverse impacts and further understand the unique experiences.
METHODS
To capture how the pandemic affected them and how they handled the challenges if there were any in the initial and more recent phases of the pandemic, 18 individuals with schizophrenia living in Turkey were interviewed.
RESULTS
Thematic analysis of interviews resulted in four superordinate themes for both time points. Three themes related to the impact of the pandemic (i.e. burdens of COVID-19, positive impacts of COVID-19, no impact of COVID-19) indicated that they shared a number of challenges with the general population. Themes about the positive impacts and no impact also replicated the previous findings in this clinical population. One last theme named as facilitators of coping implied that the participants tried to deal with the burdens by using available resources, adapt to the changes in their daily living, and benefit from social interaction and support.
CONCLUSIONS
To conclude, people with schizophrenia seem to be coping with challenges posed by the pandemic with diverse strategies and they seem to even experience psychological growth alongside with negative impacts. The individualized needs and potential for growth have pivotal implications for the management of the illness during the pandemic.
Identifiants
pubmed: 35311388
doi: 10.1177/00207640221081800
pmc: PMC10076154
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-285Références
Mil Med. 2021 Aug 28;186(9-10):e956-e961
pubmed: 33377975
Gen Psychiatr. 2020 Apr 16;33(2):e100183
pubmed: 32420521
Curr Opin Psychiatry. 2021 May 1;34(3):203-210
pubmed: 33587494
BJPsych Open. 2021 Jan 12;7(1):e35
pubmed: 33431109
World Psychiatry. 2020 Jun;19(2):129-130
pubmed: 32394569
JAMA Psychiatry. 2020 Sep 1;77(9):891-892
pubmed: 32242888
Schizophr Bull. 2018 Feb 15;44(2):242-249
pubmed: 28637195
Brain Sci. 2021 Jul 13;11(7):
pubmed: 34356160
Int J Soc Psychiatry. 2021 Nov;67(7):830-832
pubmed: 32633183
Schizophr Bull. 2021 Apr 29;47(3):624-634
pubmed: 33089862
Br J Psychiatry. 2021 Jun;218(6):344-351
pubmed: 33407954
Transl Psychiatry. 2020 Nov 24;10(1):411
pubmed: 33235185
Int J Soc Psychiatry. 2020 Sep;66(6):525-527
pubmed: 32349580
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1447-1457
pubmed: 33665680
Int J Soc Psychiatry. 2017 Nov;63(7):657-665
pubmed: 28831855
Psychiatry Res. 2021 May;299:113856
pubmed: 33740483
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
Psychiatry Res. 2020 Sep;291:113265
pubmed: 32763536
Psychiatry Res. 2020 Jul;289:113044
pubmed: 32388177
Psychol Med. 2021 Apr;51(6):1054-1056
pubmed: 32423496
Lancet. 2009 Jan 31;373(9661):408-15
pubmed: 19162314
Int J Soc Psychiatry. 2021 Nov;67(7):892-906
pubmed: 33794717
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
Int J Soc Psychiatry. 2021 Aug;67(5):540-549
pubmed: 33016171
Psychol Trauma. 2020 Aug;12(S1):S55-S57
pubmed: 32551762
Gen Psychiatr. 2020 Apr 20;33(2):e100222
pubmed: 32420523
Psychiatr Serv. 2020 Nov 1;71(11):1188-1190
pubmed: 32878542
Int J Soc Psychiatry. 2019 Mar;65(2):98-106
pubmed: 30618321
Psychiatry Res. 2020 Dec;294:113493
pubmed: 33038789
J Psychiatr Res. 2022 Feb;146:179-185
pubmed: 34995993
Braz J Psychiatry. 2020;42(3):236-238
pubmed: 32294689
J Ment Health. 2021 Jul 29;:1-8
pubmed: 34323635
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Med J Aust. 2003 May 5;178(S9):S67-70
pubmed: 12720526
J Psychiatry Neurosci. 2005 May;30(3):187-93
pubmed: 15944743
Schizophr Res. 2020 Apr;218:36-37
pubmed: 32327314
Schizophr Res. 2020 Aug;222:3-5
pubmed: 32473931